Handbook/Tissue Repair & Healing/BPC-157 + TB-500 Combo (15mg+15mg)

BPC-157 + TB-500 Combo (15mg+15mg)

Also known as: BPC/TB Stack 15mg, High-Dose Healing Duo, Extended Healing Stack

The highest-dose pre-mixed BPC-157 and TB-500 combination for extended healing protocols.

Overview

This maximum-dose combination contains 15mg each of BPC-157 and TB-500, providing the most doses per vial for extended or intensive healing protocols. Ideal for those with chronic injuries or who prefer fewer reconstitutions over long treatment periods.

Mechanism of Action

Same as other BPC/TB combos: BPC-157 promotes angiogenesis, tissue repair, and GI healing; TB-500 enhances cell migration and reduces inflammation. Combined for comprehensive healing.

Pharmacokinetics

Same as individual components. Maximum total peptide per vial for cost-effectiveness.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Intensive Healing

Dose

250-500 mcg each

Frequency

Daily or 5 days/week

Duration

12+ weeks

Maximum doses per vial

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Additional healing

Synergy: Third healing pathway

Research Areas

Chronic InjuriesExtended HealingIntensive RecoveryAthletic Rehabilitation

Key Research Findings

  • 1Maximum dose per vial option
  • 2Most cost-effective for extended use
  • 3Same mechanisms as lower-dose combos
  • 4Popular for serious/chronic conditions

Side Effects & Contraindications

Reported Side Effects

  • Injection site reactions
  • Headache (rare)
  • Fatigue

Contraindications

  • Active cancer (theoretical)
  • Recent surgery (wait for MD clearance)

Safety Considerations

Same as other BPC/TB combos. Research compounds. Individual dosing unchanged - more total doses per vial.

Storage Requirements

Refrigerate 2-8°C after reconstitution

Scientific References

Quick Reference

Sequence
Combination product
Molecular Weight
Variable
Half-Life
Variable by component
Bioavailability
Injectable
Research Stage
preclinical
Administration
Subcutaneous injection